In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

See also:

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 09, 2022

    In Surprise Move, Panel Stops Adding Cases To Opioid MDL

    The Judicial Panel on Multidistrict Litigation unexpectedly ruled late Friday that a huge and historic MDL for opioid crisis lawsuits against pharmaceutical companies has accomplished key objectives and doesn't offer enough remaining upsides to warrant the addition of future cases.

  2. April 08, 2022

    Big Pharma Can't Beat SF Opioid Claims Before Trial

    Teva Pharmaceuticals, Allergan, Anda Inc. and other drugmakers and distributors can't escape San Francisco's claims in an upcoming bellwether bench trial, the California federal judge overseeing the multidistrict opioid litigation has ruled, but Endo International can beat allegations attributed to its subsidiaries.

  3. April 05, 2022

    'Intense Pressure' To Ink Opioid Deal? Too Bad, 6th Circ. Says

    The Sixth Circuit on Tuesday swatted away protests from Walgreens and Walmart about "extraordinary, unusual pressure" to strike a settlement after a jury blamed them for out-of-control opioid sales, clearing the way for the first damages trial against pharmacy giants in multidistrict litigation.

  4. April 04, 2022

    Opioid MDL Judge Cites Miss Piggy To Explain Time Limits

    The California federal judge overseeing an upcoming bellwether bench trial in multidistrict opioid litigation explained the strict time limits he put on the trial's testimony Monday, declaring that like Miss Piggy, "Opioid trial, c'est moi."

  5. March 23, 2022

    Opioid MDL Bellwether In SF Gets 'Shocking' Cut To Trial Time

    An impending bellwether trial involving San Francisco and several drug companies in multidistrict opioid litigation will be among the shortest opioid trials yet despite shaping up as one of the largest, a California federal judge said Wednesday, an admittedly startling move accompanied by other streamlining efforts.

  6. March 22, 2022

    Pharmacy Attys Risking Opioid MDL Sanctions, Judge Warns

    Lawyers for CVS Pharmacy, Walgreens and Walmart will face discipline if they don't swiftly rectify noncompliance with a "clear and simple" directive to outline remedies after a jury blamed the companies for inundating communities with prescription narcotics, the top judge in multidistrict opioid litigation warned.

  7. March 11, 2022

    Key Opioid Cases To Watch As Massive Wave Of Trials Looms

    Despite sweeping settlements and landmark verdicts, the nation's epic saga of opioid crisis litigation against Big Pharma is far from winding down, with the coming weeks heralding an unprecedented torrent of trials. Here, Law360 shares a detailed map of the opioid trials terrain and explores major lawsuits that are rapidly approaching moments of truth.

  8. March 11, 2022

    6th Circ. Orders Opioid MDL Judge To Unfreeze Cases

    The Sixth Circuit on Friday ordered the Ohio federal judge overseeing opioid multidistrict litigation to rule on remand motions from three Texas counties and two New Mexico cities, finding that the cases have been pending for an "unduly long time."

  9. March 11, 2022

    Schools End Opioid Claims Against J&J, Distributors

    Roughly 40 school districts, largely in Maine, have agreed to end opioid-related claims against Johnson & Johnson following negotiations with the state attorney general to receive a cut of a $26 billion global deal struck in nationwide litigation, an attorney for the schools told Law360 Friday.

  10. March 07, 2022

    CVS, Walgreens, Walmart Can't Escape Opioid Verdict

    The Ohio federal judge overseeing multidistrict litigation over the opioid crisis on Monday refused to strike a jury verdict that held major pharmacy chains liable for fueling the crisis in two Ohio counties, finding there was sufficient evidence at trial for the jury to make its decision and rejecting a request for a new trial.